
AlterEcho.IO is a technology company revolutionizing aseptic manufacturing by enabling remote operation of production lines to enhance sterility and efficiency. Their solution eliminates the need for human presence in sterile cleanrooms, drastically reducing contamination risks and operational delays caused by traditional gowning and disinfection protocols. The system allows operators to control aseptic processes remotely, improving equipment efficiency by over 30%, reducing contamination chances by 95%, and recovering 20% in revenue while cutting plastic waste by 45%. AlterEcho integrates seamlessly into existing workflows, setting new standards in compliance, operator health, and sustainability, and fostering inclusivity by making aseptic roles accessible to a diverse workforce. The company is based in Denmark and led by CEO Marco Molinari and CTO Søren Myhre Voss, with a focus on transforming pharmaceutical manufacturing and sterile production environments through advanced robotics and automation technology.

AlterEcho.IO is a technology company revolutionizing aseptic manufacturing by enabling remote operation of production lines to enhance sterility and efficiency. Their solution eliminates the need for human presence in sterile cleanrooms, drastically reducing contamination risks and operational delays caused by traditional gowning and disinfection protocols. The system allows operators to control aseptic processes remotely, improving equipment efficiency by over 30%, reducing contamination chances by 95%, and recovering 20% in revenue while cutting plastic waste by 45%. AlterEcho integrates seamlessly into existing workflows, setting new standards in compliance, operator health, and sustainability, and fostering inclusivity by making aseptic roles accessible to a diverse workforce. The company is based in Denmark and led by CEO Marco Molinari and CTO Søren Myhre Voss, with a focus on transforming pharmaceutical manufacturing and sterile production environments through advanced robotics and automation technology.
Location: Copenhagen, Denmark
Product: Remote-embodiment robotics for aseptic/cleanroom operations
Founders / leadership: CEO Marco Molinari; CTO Soren Myhre Voss
Claimed impact: Improves equipment efficiency >30%, reduces contamination risk ~95%, cuts plastic waste ~45%
Funding snapshot: Pre-seed / grant activity reported; total funding entry shown as $150,000 (USD) in one source
Aseptic pharmaceutical manufacturing, sterile compounding, and specialty labs where human entry into cleanrooms creates contamination risk and operational inefficiency.
2025
Life sciences / pharmaceutical manufacturing automation
Announced Jan 1, 2025; closed Feb 21, 2025 per funding record; some sources characterize a recent round as a grant led by Innovation Fund Denmark in broader profile listings.
“Techstars participation and an Innovation Fund Denmark grant listed in profiles”